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Abstract
In recent years, chronic degenerative diseases such as certain types of cancers, are becom-
ing an evident issue. DNA damage has been for long recognized as a causal factor for can-
cer development because mutations or chromosomal aberrations affect oncogenes and
tumor suppressor genes leading cells to malignant transformation and to the subsequent
cancerous growth. Medicinal plants are often used for the prevention or treatment of various
diseases with great scientific interest. Among the medicinal plants distributed in the Mediter-
ranean region, Fraxinus angustifolia Vahl. has been used in traditional medicine for its
remarkable curative properties. However, in spite of this popularity, little works have been
performed on the activity so that further studies should be performed to investigate in depth
the antimutagenic, antigenotoxic and antiproliferative activities of the plant. Thus, the pres-
ent study was aimed to the evaluation of the potential antimutagenic, antigenotoxic and
antiproliferative properties of leaves and stem bark extracts of this well-known tree. Antimu-
tagenic activity was evaluated by Salmonella mutagenicity assay in Salmonella typhimurium
TA98 and TA100 strains. The antigenotoxic potential was assessed by umu test in the strain
of S. typhimurium TA1535/pSK1002. Antiproliferative activity was studied on human hepa-
toblastoma (HepG-2) and on breast adenocarcinoma (MCF-7) cell lines by MTT assay. Fur-
thermore, the antiproliferative activity observed on cancer cells was compared with that on
the human normal-like fibroblasts (TelCOFS02MA) and the selectivity index was calculated
to understand if extracts were able to exert selective toxicity towards cancer cells. Moreover,
phenolic compounds are plant substances with a large spectrum of biochemical activities
with antioxidant, antimutagenic and anticarcinogenic effects. Based on the strong evidence
of biological activities of phenolic compounds, the study was focused on the determination
of total phenolics and flavonoids contents, and the phytochemical composition of the
extracts assessed by LC/MS. The ethanol extracts of both leaves and stem barks showed
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significant from moderate to strong antimutagenic and antigenotoxic effects. In addition,
selective cytotoxicity towards cancer cells was shown by ethanolic leaves extract and aque-
ous/chloroform leaves and stem bark extracts. The latter showed high levels of total pheno-
lic contents among all the other extracts. Identified phenylethanoids (calceolariosides,
verbascoside) and secoiridoids (oleuropein and ligstroside) could be responsible for the
demonstrated broad spectrum of healthy properties.
Introduction
Natural products still play a leading role in the treatment of various diseases in diverse forms
e.g. extracts, fractions or as a chemical platform. In the history of humanity, plants have always
been the most popular source of medicines, mainly thanks to their secondary metabolites with
many pharmacological properties. The knowledge of the various healing properties of plants
has been transmitted primarily in an empirical way based on folk traditions, and then validated
with scientific evidences [1]. At present, one of the hottest topic in medicine is focused on nat-
ural bioactive products in the prevention and/or treatment of chronic diseases which have
been characterized as the public health challenge of the 21st century. In fact, as explained by
Lunenfeld and Stratton [2], in developed countries the rise in healthcare systems and life
expectancy, as well as the decrease in fertility rate mainly due to chromosomal abnormalities
lead to a rapid increase in the world population aging with consequent chronic degenerative
disease increase. In line with the World Health Organization (WHO, 2018), cancer is the sec-
ond chronic disease (9.6 million deaths in 2018), and cancers of liver (782 000 deaths) and
breast (627 000 deaths) are among the most common causes of cancer death. As reported [3],
the DNA damage has been long recognized as causal factor for cancer development. In fact,
mutations or chromosomal aberrations affect oncogenes and tumor suppressor genes leading
cells to malignant transformation. Hence, antimutagenic, antigenotoxic and anticarcinogenic
substances play a major role in the primary prevention of cancer development [4, 5].
In recent years, a wide range of medicinal plants and their metabolites have been studied
for their potential to decrease the mutagenic and carcinogenic effects of potentially damaging
chemicals [6, 7]; in fact, these natural compounds are able to inhibit free radicals and oxidative
stress-induced DNA and cellular damages [8, 9].
One of medicinal plants widely distributed in the Mediterranean region is Fraxinus angusti-
folia Vahl a medium-sized deciduous tree, belonging to the Oleaceae family. The plant is
extensively used in traditional medicine for its remarkable curative properties. In Algerian folk
medicine, different parts of this plant are used to treat many inflammatory diseases [10]; leaves
and fruits (samaras) are used in decoctions and infusions as anti-rheumatism, while bark is
effective for curing hemorrhoids and fever [11]. Moreover, a mixture composed of powder of
samaras, olive oil and honey is used against gonorrhea [12]. Moreover, an exudate from the
bark of F. angustifolia Vahl. or F.ornus L., called manna, collected in Southern Italy, is used in
case of digestive problems [13] as well as expectorant and sedative in cough [14, 15]. When
taken in hypertonic solutions, manna acts as a dehydrating agent in the treatment of wounds,
ulcers and promotes the flow of the contents of the gall bladder and bile ducts [16, 17].
According to European Medicines Agency (EMA) [18], the biological activities of F. angu-
stifolia Vahl. in traditional applications is attributed to the phytochemical constituents; e.g. fla-
vonoids, coumarins, iridoids and secoiridoids having anti-inflammatory and analgesic effects
(laxative and diuretic effects might be associated with to mannitol). Recently, based on the
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chemical structure study [19], phenylethanoids such as calceolariosides (A and B) and verbas-
coside are the major antioxidants of stem bark extracts of F. angustifolia Vahl. Furthermore,
verbascoside was also identified in leaves fractions, in addition to secoiridoids (oleuropein and
ligstroside) and at least three flavonoides glycosides: kaempferol 3-O-rutinoside, isoquercetrin
(quercetin 3-O-glucoside) and rutin (quercetin 3-O-α-L-rhamnopyranosyl-1-6-glucopyra-
nose) which were responsible for leaves antioxidant potential. Furthermore, the latter could
also be behind the anti-enzymatic [20–22], antidiabetic, and hepatoprotective [23], as well as
wound healing properties [24].
However, to the best of our knowledge, in spite of this popularity, the antimutagenic, anti-
genotoxic and antiproliferative activities of F. angustifolia Vahl leaves and stem bark extracts
had never been tested. In this context, the present study aimed to evaluate the antimutagenic,
antigenotoxic and antiproliferative properties of F. angustifolia Vahl. leaves and stem bark
extracts, and to extend the knowledge on their phytochemical composition.
The antimutagenic activity was evaluated by the Salmonella mutagenicity assay (Ames test)
in Salmonella typhimurium TA98 and TA100 strains, auxotrophs for histidine (His-). Further-
more, the antigenotoxic potential was assessed by umu-test in S. typhimurium TA1535/
pSK1002. Both antimutagenic and antigenotoxic assays were performed with and without liver
homogenate (S9) to find out if metabolizing enzymes were involved in the activation of these
natural compounds. Obviously, before beginning antimutagenic and antigenotoxic assays,
Ames and umu tests were performed also to assess the eventual mutagenicity and genotoxicity
of F. angustifolia Vahl. extracts.
Antitumor potency was studied by testing F. angustifolia Vahl. leaves and stem bark extracts
on human hepatoblastoma (HepG-2) and on breast adenocarcinoma (MCF-7) cell lines (two
among the most widespread cancers) by MTT assay. Then, to understand if extracts were able
to exert selective toxicity towards cancer cells, the antiproliferative activity observed on cancer
cells was compared with that of the human normal-like fibroblast cell line (TelCOFS02MA).
Moreover. In order to study the chemical basis of the results obtained, the polyphenolic
composition of most active extracts of F. angustifolia Vahl. were characterised after fraction-
ation using HPLC/MS method.
Materials and methods
Reagents
Ethanol (CAS: 64-17-5), Ethyl acetate (CAS: 141-78-6) and Chloroform (CAS: 67-66-3) were
purchased from Prolabo (Sion, Switzerland). Aroclor 1254-induced male Sprague Dawley rat
liver (S9) was purchased from TrinovaBiochem GmbH (Giessen, Germany). Sodium azide
(NaN3, CAS: 26628-22-8) was from JT Baker (Milano, Italy). 2-Nitrofluorene (2-NF, CAS:
607-57-8), 2-amino-anthracene (2-AA, CAS: 613-13-8), 3-methylcholanthrene (3-MC, CAS:
56-49-5), 4-nitroquinoline-1-oxide (4-NQO, CAS: 56-57-5), Cyclophosphamide (CP, CAS:
6055-19-2), L-histidine (CAS: 71-00-1), Biotin (CAS: 58-85-5), and O-Nitrophenyl-β-D-galac-
topyranoside (ONPG, CAS: 369-07-3), 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyl-tetrazolium
bromide (MTT, CAS: 298-93-1) were purchased from Sigma-Aldrich (Milano, Italy). HEPES
and Roswell Park Memorial Institute medium (RPMI 1640) were supplied by Lonza BioWhit-
taker (Verviers, Belgium).
Sample collection and extraction procedure
Fraxinus angustifolia Vahl. leaves (FL) and stem bark (FB) were collected in July 2014 in
remote areas of Chemini (963 m altitude, 36˚350 latitude and 4˚360 longitude), located in the
department of Bejaia (Northeastern Algeria). F. angustifolia Vahl is not on the list of protected
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species, therefore no permission is required to collect it according to Algerian legislation [Art.
4 n˚12–03 of 4/01/2012]. A voucher specimen, with the number (O/n˚59), taxonomically vali-
dated by Professor Hacène Abdelkrim. was deposited in the herbarium of Department of Bot-
any, ENSA (Ecole Nationale des Sciences Agronomiques), El-Harrach (Algiers, Algeria).
Leaves and stem bark samples were shade dried at room temperature, then ground into fine
powders using an electric blender (KIKA, Labortechnic,Staufen, Germany). Phenolic com-
pounds were extracted following the procedure described [25] and modified [26]. An amount
of 100 g of each plant material was macerated in ethanol 96% (1:4 w/v) for 24 h under continu-
ous stirring. After decantation, supernatants were dried using a rotavapor (HEIDOLF). The
crude ethanolic extracts (FL1 and FB1, for leaves and stem bark, respectively) were further par-
titioned using ethyl acetate and distilled water (1:3:1/w:v:v) leading to ethyl acetate fractions
(FL2 and FB2) and their respective aqueous fractions (FL3 and FB3). The FL2 and FB2 frac-
tions were then partitioned between chloroform and distilled water (1:3:1/w:v:v) in order to
obtain chloroform (FL4 and FB4) and aqueous (FL5 and FB5) fractions.
Salmonella mutagenicity assay (Ames test)
The mutagenic and antimutagenic activities of F. angustifolia Vahl. extracts were evaluated by
the Salmonella/microsome assay, using TA98 and TA100 S. typhimurium strains [27, 28]. Sal-
monella strains were from the permanent collection of the Laboratory of Hygiene and Environ-
mental Toxicology, University of Campania, Italy. TA98 strain was used to observe frame-shift
mutations, while TA100 was used to assess base-pair substitutions due to missense mutations.
Briefly, 100 μL of S. typhimuriumTA98 or TA100 cultured overnight (108 cells), 100 μL of
extract at 1000 μg/mL, chosen as the highest concentration for genotoxicity assessment, and
500 μL of phosphate buffer (0.1 M, pH = 7.4), or S9 mixture (lyophilized S9, 1 M NADP, 1 M
Glucose-6-phosphate, 0.1 M Phosphate buffer pH 7.4, 0.4 M MgCl2, 0.4 M KCl) in case of meta-
bolic activation, were added to 2.5 mL of 0.5 M histidine-biotin top agar, and then poured onto
minimal glucose agar, in triplicate. Furthermore, 2-NF at 2.5 and 5 μg/mL for TA98, and NaN3
at 5 and 10 μg/mL for TA100 were used as direct positive controls in absence of metabolic acti-
vation. Moreover, 25 and 50 μg/mL of 3-MC for TA98, 50 and 100 μg/mL of CP for TA100
were used as indirect positive controls in presence of metabolic activation. saline solution (0.9%
NaCl) was used as negative control. After incubation (37˚C/72 h), induced His+ revertants were
counted and statistically compared to the number of spontaneous revertants on the negative
control plate. Plates count after 72h instead of 48h was chosen to facilitate the reading.
The mutagenic ratio (MR) was calculated for each tested extract as the ratio between the
average number of revertants per plate of the test compound and the average number of spon-
taneous revertants per plate of the negative control. A sample was considered mutagenic when
a two-fold increase in the number of mutants (MR� 2) was observed.
For the antimutagenic assay, three different concentrations of the extracts (25, 50 and 100 μg/
mL, chosen starting dilutions from the highest concentration of the value 1/10 lower than the con-
centration used to evaluate the eventual mutagenic effect, 1000 μg/mL) were pre-incubated with
direct and indirect mutagens for 2 h at 37˚C. The results were expressed as the percentage of the
ability of the extracts to inhibit the action of the mutagen, calculated as follows:






Where T is the mean number of revertant colonies in the plate containing both mutagen
and test compounds, M is the mean number of revertant colonies in the plate containing only
the mutagen [29].
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No antimutagenic effect was recorded when inhibition was lower than 25%, a moderate
effect for an inhibition value between 25% and 40%, and strong antimutagenicity for values
greater than 40% [29].
Umu test
The SOS/umu bioassay detects the induction of the SOS-repair system in the S. typhimurium
TA1535/pSK1002 strain, whose plasmidcarries the umuC:lacZ fusion gene with the β-galacto-
sidase activity strictly dependent on umuC expression in response to specific DNA damaging
agents [30]. The S. typhimurium TA1535/pSK1002 (optical density of� 800 Formazine
Nephelometric Units, FNU) was purchased by EBPI (Burlington, Ontario, Canada) and cul-
tured in tryptone, glucose and ampicillin (TGA)-culture medium at 37˚C for 12 h, and then
was ten-fold diluted. After 2 h-reincubation, 70 μL of exponentially growing bacteria (340–350
FNU) were mixed with 180 μL of the respective extract (1000 μg/mL), chosen as the highest
concentration for genotoxicity assessment, and 20 μL TGA medium (ten-fold concentrated)
into each well of the 96-well microplate, in triplicates. Moreover, saline solution (0.9% NaCl)
was used as negative control, 4-NQO (0.05 μg/mL) and 2-AA (0.2 μg/mL) were used as posi-
tive controls in the absence and presence of S9, respectively. The blank contained 70 μL of
TGA medium instead of the 70 μL of the bacterial culture. For the determination of indirect
genotoxins, 450 μL of S9 mix (lyophilized S9, 1 M NADP and 1 M Glucose-6-phosphate) were
added to 15 mL of bacterial medium. After incubation for 2 h at 37˚C under shaking at 150
rpm, 30 μl from each well were transferred in a new microplate containing fresh medium and
re-incubated for a second time. The density of the strain was monitored by measuring the
absorbance at 620 nm using a microplate reader (TecanSPECTRAfluor, Männedorf,
Switzerland).
For the determination of β-galactosidase activity, 30 μL of TGA medium was mixed with
120 μL of B-buffer (0.1 M sodium phosphate pH 7.4, 10 mM KCl, 1 mM MgSO4, 1 mg/L β
-mercaptoethanol, 10 μL of SDS 1 mg/mL) and the enzymatic reaction was activated by adding
30 μL of 4.5 mg/mL ONPG. After 30 min of incubation at 28˚C, 120 μL Na2CO3 (1M) were
added to stop the reaction. The absorbance was recorded at 420 nm.
Genotoxicity was quantified by induction ratio (IR) which is the ratio of absorbance at 420
nm of the sample (T) and of the negative control (N), corrected for growth rate at 620 nm. The
sample is considered genotoxic when the induction ratio (IR) is equal to or higher than 1.5,








Where: A420 is the absorbance at 420 nm relative to enzymatic reaction intensity of samples
(T) and blank (B); while A620 is the absorbance at 620 nm of bacteria growth of samples and
blank.
The antigenotoxicity assay was conducted using the same procedure of the genotoxicity
assay described above. Three different concentrations of extracts (25, 50 and 100 μg/mL, cho-
sen starting dilutions from the highest concentration of the value 1/10 lower than the concen-
tration used to evaluate the eventual genotoxic effect, 1000 μg/mL) were pre-incubated for 2 h
at 37˚C with known genotoxins, 4-NQO and 2-AA in the absence and presence of metabolic
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activation S9, respectively. The percentage of antimutagenicity was calculated [31]:
%Antimutagenicity ¼ ½1  ðbgal unitGENOTOXINþSAMPLE=bgal unitGENOTOXINÞ� � 100
The extract was considered as a strong antigenotoxic when its activity is above 70%,
medium when it’s between 40 and 70% and neutral when lower than 40% [32].
MTT assay
The antiproliferative activity of F. angustifolia Vahl. leaves and stem bark extracts was per-
formed using the tetrazolium dye colorimetric test (MTT assay) [33] on Hep-G2 and MCF-7
cell lines. The cells used were provided by Prof. Abbondanza, Department of Precision Medi-
cine, University of Campania. Periodic quality control testing procedures (authentication,
characterization and mycoplasma testing) were performed. The test is based on the activity of
mitochondrial reductases that convert tetrazolium salts into formazan, obtaining a purple
solution in living cells. Briefly, cells were grown in RPMI1640 medium with 10% fetal bovine
serum (FBS), 2% HEPES, 2% L-Glutamine, and 1% penicillin/streptomycin (10,000 U/mL),
and were cultured in T-75-cm2 tissue culture flasks in humidified atmosphere of 95% air plus
5% CO2 at 37˚C. When the cells were at 80%–90% of confluence; they were collected and
counted with the vital dye trypan blue. The cells (1×104/well) were seeded in quadruplicate
wells of 96-well plates. After 24 h incubation at 37˚C, the medium was removed and replaced
with 200 μL of different concentrations (50 to 2000 μg/mL, chosen after range finding tests) of
F. angustifolia Vahl. leaves and stem bark extracts dissolved in RPMI, chosen after range find-
ing tests. The plates were then incubated for 72 h at 37˚C. Each plate had negative control
wells containing only the medium. After that, 20 μL of yellow MTT solution (5 mg/mL) was
added to each well and the plates were re-incubated for 4 h at 37˚C. Hence, the culture
medium was removed and 200 μL /well of 2-propanol was used for dissolving the formazan.
The absorbance of formazan was measured spectrophotometrically at 590 nm. The results
were reported as inhibition cell (IC) percentage:





Independent experiments were pooled and statistically analysed by Prism 5.03 version
(GraphPad Inc., San Diego, CA, USA). Thus, IC50 values were calculated by non-linear con-
centration/response regression model.
Furthermore, selectivity index (SI) was calculated [34] to compare the antiproliferative
activity observed on cancer cells with that of the human normal-like fibroblast cell line (Tel-
COFS02MA, ATCC1 CRL 4005™ purchased from American Type Culture Collection, Milan,
Italy). A selective toxicity towards cancer cells occurs when SI value is greater than 2. SI value




Determination of total phenolics and flavonoids contents
The total phenolics contents of F. angustifolia Vahl. extracts were quantified by the Folin-Cio-
calteu method and the amounts of phenolics were calculated from catechin standard curve
[35]. Flavonoids contents were determined by the aluminium chloride procedure [36] and
deduced from a rutin standard curve to be expressed as μg of catechin equivalent/mg of dry
extract.
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UHPLC/MS investigation
The LC-MS analyses were carried out on the apparatus consisting of the following elements:
Dionex Ultimate 3000 UHPLC system equipped with a quaternary pump (RS pump), an auto-
sampler (RS autosampler) and UV detector with diode arrays (PE 785 A) linked to a high-reso-
lution triple-quadrupole mass spectrometer (Brucker micro OTOF-QII, Bremen, Germany),
equipped with an electrospray ionisation interface. The ethanolic extracts and their respective
fractions of leaves and stem barks of F. angustifolia Vahl. (1 mg/mL) were injected onto a C18
Symetry HPLC column (Waters) (3.5 μm, 75 x 4.6 mm). The separations were carried out at
room temperature with a mobile phase consisting of two water-acid solvents. Formic acid
0.1% (A) and methanol-0.1% formic acid (B) under the following conditions: 0 to 15 min, 13%
B for 15 min, then in 5 min a linear gradient of 55 to 85% B then 85% B for 1 min, finally,
return to the initial conditions (15% B) in 2 minutes to rebalance the column before any new
injection. For all analyses, the solvents used are of HPLC quality, the flow rate was set at 0.350
mL/min, and the measurement wavelengths were set at 280, 360 and 450 nm. For comparative
purposes, the injection volume and the concentrations of the injected solutions were fixed at
5 μL and 1 mg/mL, respectively, for all injected extracts and fractions.
Statistical analysis
Tests were from three independent experiments. The results were expressed as mean and stan-
dard deviation. Analysis of variance (one-way ANOVA model) was performed in combination
with Dunnett’s post-test for multiple comparisons. Differences from the controls were consid-
ered significant as �p< 0.05, ��p< 0.001, ���p< 0.0001. GraphPad Prism 5.03 version soft-
ware was used for all statistical assessments.
Results
Mutagenicity/genotoxicity
Before the assessment of the protective effects of F. angustifolia Vahl. extracts, Ames and umu
tests were also used to study, respectively, the eventual mutagenic and genotoxic effects of these
extracts. At 1000 μg/mL, they did not reveal any mutagenic effect, as reported in S1 and S2 Figs.
In fact, in S. typhimurium TA 98 and TA 100 strains, there were observed neither direct/indirect
frame-shift mutations nor direct/indirect missense mutations (M R< 2) were observed. Simi-
larly, no direct/indirect genotoxic effects were observed (S1 Table) indicating no induction of
the SOS-repair system in the S. typhimurium TA1535/pSK1002 strain (IR< 1.5).
Antimutagenicity
Results of antimutagenic activity with and without metabolic activation are presented respec-
tively in Tables 1 and 2, as the mean of revertants/plates ± SD of three independent experi-
ments (each one based on three replicates). Inhibition rate percentage was calculated [29].
Basically, significant moderate and strong antimutagenic effects exerted by F.angustifolia Vahl.
leaves and stem bark extracts were observed in S. typhimurium strains. Three concentrations
(25, 50 and 100 μg/mL) of extracts were co-incubated for 72h with standard direct mutagens.
Altogether, inhibition rate percentage values, calculated for TA100, were higher than those of
TA98 (Table 1).
Thus, extracts were mainly able to inhibit the direct mis-sense mutations caused by both
concentrations of NaN3 (5 and 10 μg/mL) in TA 100, but were less active in inhibiting direct
frame-shift mutations towards the higher concentration of 2-NIT (5 μg/mL) in TA 98. Specifi-
cally, FL2, FL4, FB1, FB2, FB4 did not induce significant inhibition of the frame-shift
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mutations induced by 2-NIT (5 μg/mL). Indirect antimutagenicity experiments, were per-
formed only at 25 μg/mL of extracts, which was the lowest effective concentration obtained in
direct antimutagenicity experiments. Significant moderate and strong antimutagenic effects
Table 1. Direct antimutagenic activities of F. angustifolia Vahl. Antimutagenic activities of F. angustifolia Vahl. leaves and stem bark extracts on TA98 and TA100
strains after 72h co-incubation with direct mutagens, respectively 2-NF (2.5 and 5 μg/mL) and NaN3 (5 and 10 μg/mL), in the absence of metabolic activation system S9.
Treatment
[μg/mL]
TA 98 revertants/plate (mean±SD) Inhibition rate (%) TA 100 revertants/plate (mean±SD) Inhibition rate (%)
2-NF 2.5μg/mL 2-NF 5μg/mL 2-NF 2.5μg/mL 2–5μg/mL NaN3 5μg/ mLNaN3 10μg/mL NaN3 5μg/mL NaN3 10μg/mL
FL1 25 77 ± 4 ��� 183 ± 79� 52c 46c 237 ± 25 ��� 283 ± 50 ��� 49c 56c
50 88 ± 16 ��� 163 ± 59 � 46c 52c 282 ± 20 ��� 345 ± 7 ��� 39b 47c
100 99 ± 10 ��� 233 ± 3 39b 32b 250 ± 3 ��� 354 ± 8 ��� 46c 45c
FL2 25 94 ± 17 ��� 333 ± 22 42c 2a 252 ± 19 ��� 381 ± 14 ��� 45c 41c
50 96 ± 8 ��� 330 ± 44 41c 3a 222 ± 6 ��� 379 ± 13 ��� 52c 41c
100 98 ± 16��� 336 ± 11 40b 1a 213 ± 21 ��� 352 ± 18 ��� 54c 46c
FL3 25 105 ± 3�� 175 ± 72 � 35b 49c 261 ± 27 ��� 306 ± 6 ��� 43c 53c
50 95 ± 9 ��� 324 ± 62 41c 5a 242 ± 59 ��� 302 ± 14 ��� 48c 53c
100 98 ± 10 ��� 240 ± 14 40b 30b 267 ± 4 ��� 348 ± 40 ��� 42c 46c
FL4 25 77 ± 4 ��� 210 ± 13 52c 38b 290 ± 18 ��� 339 ± 44 ��� 37b 48c
50 86 ± 16 ��� 279 ± 13 47c 18a 349 ± 92 388 ± 25 ��� 24a 40b
100 88 ± 4 ��� 273 ± 16 46c 20a 252 ± 17 ��� 382 ± 48 ��� 45c 41c
FL5 25 96 ± 7 ��� 330 ± 17 41c 3a 277 ± 73 ��� 301 ± 40 ��� 40b 53c
50 98 ± 17 ��� 182 ± 73 � 40b 47c 374 ± 9 304 ± 6 ��� 19a 53c
100 111 ± 9 �� 256 ± 40 31b 25b 327 ± 16 �� 308 ± 7 ��� 29b 52c
FB1 25 81 ± 4 ��� 193 ± 80 50c 43c 225 ± 23 ��� 368 ± 5 ��� 51c 43c
50 102 ± 17 �� 332 ± 14 37b 3a 258 ± 8��� 367 ± 4 ��� 44c 43c
100 89 ± 11 ��� 240 ± 28 45c 30b 296 ± 19��� 354 ± 3 ��� 36b 45c
FB2 25 71 ± 13 ��� 306 ± 8 56c 10a 248 ± 11 ��� 365 ± 17 ��� 46c 44c
50 108 ± 17 � 332 ± 6 33b 3a 244 ± 34 ��� 314 ± 42 ��� 47c 51c
100 83 ± 16 ��� 334 ± 0 49c 2a 264 ± 23 ��� 300 ± 96 ��� 43c 54c
FB3 25 80 ± 4 ��� 218 ± 10 51c 36b 274 ± 41 ��� 314 ± 4 ��� 41c 51c
50 106 ± 6 � 173 ± 71 � 35b 33b 250 ± 5 ��� 372 ± 17 ��� 46c 43c
100 75 ± 4 ��� 230 ± 19 54c 37b 262 ± 2 ��� 350 ± 14 ��� 43c 46c
FB4 25 109 ± 29 � 323 ± 10 33b 5a 258 ± 47 ��� 358 ± 7 ��� 44c 45c
50 105 ± 9 �� 191 ± 84 35b 44c 298 ± 60 ��� 348 ± 17 ��� 35b 46c
100 76 ± 8 ��� 271 ± 58 53c 21a 366 ± 16 355 ± 33 ��� 21a 45c
FB5 25 103 ± 27 �� 279 ± 66 36b 18a 292 ± 6 ��� 351 ± 51 ��� 37b 46c
50 110 ± 6 � 211 ± 86 32b 38b 276 ± 11 ��� 326 ± 20 ��� 40b 50c
100 113 ± 6 � 154 ± 54�� 30b 55c 306 ± 89 ��� 334 ± 20 ��� 34b 48c
M 162±44 341±79 - - 461±43 647±16 - -
NC 60 ± 7 - - 220±25 - -
Results are expressed as mean of revertants/plates ± SD (three independent experiments). Inhibition rate percentage was calculated as follows: 100- [(T/M) x 100] where
T is the mean number of revertant colonies in the plate containing both mutagen and tested extract, and M is the mean number of revertant colonies in the plate
containing only the mutagen [29]. Significant difference for �p <0.05, ��p< 0.01, ��� p < 0.001 (Dunnett’s test) was calculated comparing extracts co-treated with
standard mutagens to single standard mutagens.
NC negative control; M mutagen; 2-NF 2- nitrofluorene; NaN3 Sodium Azide FL F.angustifolia Vahl. leaves; FB F.angustifolia Vahl. stem bark
1 Ethanolic; 2 Organic/Ethyl Acetat; 3 Aqueous/ Ethyl Acetat; 4 Organic/ Chloroform; 5 Aqueous/ Chloroform
aNo antimutagenic effect (< 25% inhibition)
bModerate effect (25%– 40% inhibition)
cStrong antimutagenic effect (> 40% inhibition) [29].
https://doi.org/10.1371/journal.pone.0230690.t001
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(���p< 0.0001) were observed for all extracts in presence of metabolic activation (Table 2).
Hence, protective effect towards indirect frame- shift and missense mutations was exhibited,
respectively in both TA98 and TA100, at both concentrations of standard indirect mutagens
(3-MC: 25 and 50 μg/mL; CP: 50 and 100 μg/mL).
Antigenotoxicity
Antigenotoxicity results, due to the properties of the extracts in inhibiting the SOS response in
S. typhimurium TA1535/pSK1002, were expressed as mean of induction ratio (IR) ± SD
(n = 3), and are reported in Table 3. Significant differences (��p< 0.001, ��� p< 0.0001) were
observed between IR values obtained from extracts co-treated with direct standard genotoxin
(4-NQO, 0.05 μg/mL) and IR values obtained from the single 4-NQO. Antigenotoxicity (%
mean ± SD), calculated [31], revealed a moderate or strong effect induced by all extracts
towards the direct genotoxin in absence of metabolic activation, with the highest inhibition by
FL5 and FB5 (antigenotoxicity by 70%). On the contrary, in presence of metabolic activation,
FL3, FB4 and FB5 showed a neutral effect (Antigenotoxiciy less than 40%), while FL1, FL2,
FL4 and FB1 showed significant (��p< 0.001, ���p< 0.0001) moderate to strong protective
effect against the indirect genotoxin (2AA, 0.2 μg/mL).
Antiproliferative activity
Results regarding the potential antiproliferative activity exerted after 72h (MTT assay) by F.
angustifolia Vahl. extracts on Hep-G2 and MCF-7 cell lines were expressed as IC50 values and
Table 2. Indirect antimutagenic effects of F. angustifolia Vahl. Antimutagenic effects of F. angustifolia Vahl. leaves and stem bark extracts on strains TA98 and TA100
after 72h co-incubation with indirect mutagens, respectively 3-MC (25 and 50 μg/mL) and CP (50 and 100 μg/mL), in presence of metabolic activation system S9.
TA 98 TA 100
Treatments
25μg/mL
Mean revertants/plate±SD Inhibition rate (% mean±SD) mean revertants/plate±SD Inhibition rate (% mean ±SD) b
3-MC 25μg/mL 3-MC 50μg/mL 3-MC 25μg/mL 3-MC 50μg/mL CP 50μg/mL CP 100μg/mL CP 50μg/mL CP 100μg/mL
FL1 79 ± 5 ��� 158 ± 1 ��� 40 ± 4b 32± 3b 244 ± 13 ��� 484± 13��� 43 ± 5c 29 ± 3b
FL2 87 ± 2 ��� 173 ± 6 ��� 34 ± 3b 26± 4b 226± 5��� 439± 23��� 47± 4c 35± 4b
FL3 89 ± 2 ��� 190 ± 2 ��� 32± 3b 18 ± 4a 251± 8��� 458± 2��� 41 ± 5c 32± 2b
FL4 76± 2 ��� 155 ± 4 ��� 42± 3c 33 ± 3b 300± 16 ��� 467 ± 7��� 29 ± 6c 31± 2b
FL5 76± 0 ��� 151± 6 ��� 42 ± 2c 35± 4b 252± 7 ��� 455± 4 ��� 41 ± 5c 33 ± 2b
FB1 84 ± 2 ��� 155± 2 ��� 36 ± 3b 33± 3b 263± 13 ��� 460 ± 13��� 38 ± 5c 32 ± 3b
FB2 75± 1 ��� 152± 15 ��� 43 ± 2c 35 ± 7b 240 ± 6��� 506± 30 ��� 44 ± 4c 25 ± 5b
FB3 84± 1��� 171 ± 1 ��� 36± 3b 27 ± 3b 231± 6��� 490 ± 18 ��� 46 ± 4c 28 ± 3b
FB4 88± 2 ��� 168± 2 ��� 33 ± 3b 28 ± 3b 235 ± 6��� 443± 18 ��� 45 ± 4c 35 ± 3b
FB5 80 ± 5 ��� 160 ± 2��� 39 ± 4b 31 ± 3b 229± 12��� 436 ± 21 ��� 46 ± 5c 36 ± 4c
M 131 ± 5 233± 10 - - 425± 31 677 ± 18 - -
NC 60± 7 - - - 220± 25 - - -
Results are expressed as mean of revertants/plates ± SD (three independent experiments). Inhibition rate percentage was calculated as follows: 100- [(T/M) x 100] where
T is the mean number of revertant colonies in the plate containing both mutagen and tested extract, and M is the mean number of revertant colonies in the plate
containing only the mutagen [25]. Significant difference for ���p<0.001 (Dunnett’s test) was calculated comparing extracts co-treated with standard mutagens to single
standard mutagens.
NC negative control; M mutagen; 3MC 3-Metilcolanthrene; CP Cyclophosphamide; FL F.angustifolia Vahl. leaves; FB F.angustifolia Vahl. stem bark
1 Ethanolic; 2 Organic/Ethyl Acetat; 3 Aqueous/ Ethyl Acetat; 4 Organic/ Chloroform; 5 Aqueous/ Chloroform
aNo antimutagenic effect (< 25% inhibition)
bModerate effect (25%– 40% inhibition)
cStrong antimutagenic effect (> 40% inhibition) [29].
https://doi.org/10.1371/journal.pone.0230690.t002
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Table 3. Antigenotoxicity of F. angustifolia Vahl. Antigenotoxicity of F. angustifolia Vahl. leaves and stem bark extracts (25, 50, 100 μg/mL) after 2h co-incubation with
standard genotoxins: 4-NQO 0.05μg/mL and 2-AA 0.20μg/mL, respectively for the treatment in absence and in presence of metabolic activation S9.
Treatment [μg/mL] IR ± SD
-S9 +S9
NC 0 1.00 ± 0.00 1.00 ± 0.00
4-NQO 0.05 3.13 ± 0.34 -
2-AA 0.20 - 4.56 ± 0.66
+ 4-NQO + 2-AA
IR ± SD Antigenotoxicity (% mean ± SD) IR ± SD Antigenotoxicity (% mean ± SD)
FL1 25 1.60±0.24��� 48.90 ± 0.29b 2.09± 0.36�� 54.00 ± 1.72b
50 1.56±0.17��� 50.10 ± 2.25b 2.46± 0.42 45.73 ± 1.93b
100 1.82±0.30�� 42.05 ± 0.68b 2.35± 0.33� 48.20 ± 3.34b
FL2 25 1.13±0.04��� 63.50 ± 4.55b 1.60± 0.48��� 65.29 ± 3.40b
50 1.10±0.10��� 64.63 ± 2.00b 1.77± 0.35�� 61.20±0.34b
100 1.12±0.22��� 64.22 ± 1.56b 1.57± 0.35��� 65.56 ± 0.52b
FL3 25 1.75±0.47�� 44.55 ± 6.50b 2.92± 0.40 35.55 ± 4.67a
50 1.69±0.21�� 46.05 ± 1.55b 3.25± 0.74 28.95 ± 1.59a
100 1.74±0.32�� 44.47 ± 1.69b 2.60± 0.13 41.93 ± 9.10b
FL4 25 1.24±0.23��� 60.41 ± 1.25b 1.87± 0.68�� 59.60 ± 6.65b
50 1.15±0.03��� 62.66 ± 6.78b 2.08± 0.71�� 55.10 ± 6.23b
100 1.23±0.13��� 60.64 ± 2.39b 1.64± 0.38��� 64.16 ± 0.95b
FL5 25 0.92±0.03��� 70.31 ± 5.56c 1.92± 0.23�� 57.44 ± 3.73b
50 1.13±0.02��� 63.50 ± 4.94b 2.28 ± 0.10� 49.17 ± 8.23b
100 1.03±0.04��� 66.84 ± 3.80b 2.47± 0.38 45.52 ± 3.00b
FB1 25 1.37±0.50��� 57.02 ± 9.30b 2.26± 0.82� 51.16 ± 7.96b
50 1.38±0.33��� 56.21 ± 3.87b 2.50± 0.88 46.02 ± 8.08b
100 1.41±0.32��� 55.09±3.27b 1.89± 0.40�� 58.49 ± 0.16b
FB2 25 1.19±0.26��� 62.13 ± 2.45b 2.47± 0.30 45.31 ± 4.72b
50 1.23±0.18��� 60.69 ± 021b 2.27± 0.06� 49.35 ± 9.25b
100 1.43±0.24��� 54.35±0.67b 2.66± 0.16 40.72 ± 8.65b
FB3 25 1.20±0.23��� 61.93 ± 1.48b 2.40± 0.58� 47.52 ± 1.86b
50 1.28±0.32��� 59.49 ± 3.96b 2.60± 0.71 43.36 ± 3.84b
100 1.47±0.48��� 53.80±8.08b 2.45± 0.71� 46.71 ± 4.53b
FB4 25 1.26±0.36��� 60.08 ± 5.24b 2.93± 0.93 36.48 ± 7.18a
50 1.38±0.16��� 55.64 ± 1.71b 2.87± 0.28 36.37 ± 6.92a
100 1.45±0.12��� 53.49±3.39b 2.43± 0.10� 45.70 ± 9.00b
FB5 25 1.12±0.22��� 64.26 ± 1.41b 2.66± 0.25 40.87 ± 6.64b
50 1.17±0.16��� 62.45 ± 0.84b 2.91± 0.17 35.11 ± 9.65a
100 1.00±0.11��� 67.94±1.37b 2.63± 0.24 41.50 ± 6.94b
Results are expressed as mean of induction ratio (IR) ± SD (n = 3) with significant difference for �p <0.05, ��p< 0.01, ��� p < 0.001 (Dunnett’s test) calculated
comparing IR values obtained from extracts co-treated with standard genotoxins to IR values obtained from single standard genotoxins. Antigenotoxicity (%
mean ± SD) was calculated as follows: [1-(βgalactosidase unit GENOTOXIN+SAMPLE / βgalactosidase unit GENOTOXIN)] �100%, [31].
NC negative control; 4-NQO 4-nitroquinoline; 2AA 2-amino-anthracene
FL F.angustifolia Vahl. leaves; FB F.angustifolia Vahl. stem bark
1 Ethanolic; 2 Organic/Ethyl Acetat; 3 Aqueous/ Ethyl Acetat; 4 Organic/ Chloroform; 5 Aqueous/ Chloroform
aNeutral effect (< 40% Antigenotoxicity)
bModerate effect (40%– 70% Antigenotoxicity)
cStrong effect (>70% Antigenotoxicity) [32].
https://doi.org/10.1371/journal.pone.0230690.t003
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are reported in Table 4. Almost completely overlapped 95% confidence intervals of IC50 values
were found in all extracts. In addition, the lowest observable adverse effect concentrations
(LOAECs, p< 0.05) were observed with FL5 (125 μg/mL), FB3 and FB5 (250 μg/mL) on Hep-
G2, while FB4 (100 μg/mL), FB5 (125 μg/mL), FL1 and FL5 (250 μg/mL) were obtained on
MCF-7. Furthermore, IC50 values of the antiproliferative activity exerted by the extracts on
normal-like cells (TelCOFS02MA) were used to calculate SI [34]. Selective toxicity towards
cancer cells was shown by FL1 (SI: 2.04, Hep-G2; 2.93, MCF-7), FL5 (SI: 2.40, Hep-G2; 2.21,
MCF-7) and FB5 (SI: 2.52, Hep-G2; 2.90, MCF-7).
Phytochemical investigation
Solvent extraction yield and quantification of total phenolics and flavonoids. Extrac-
tion yield from raw plant material, total phenolics and flavonoids are reported in Table 5. Etha-
nolic extracts FL1 and FB1 exhibited a high percentage, 8.5 and 5.9%, respectively. While, the
aqueous/chloroform extract FL5 and FB5 showed the lowest percentages (0.7; 0.5%) among all
other extracts.
All extracts exhibited the presence of various quantities of total phenolics and flavonoids
contents. Leaves extracts contained approximately the same amount of total phenols as the
corresponding stem bark extract, while the most prominent being that of the aqueous chloro-
form fractions (FB5) with 207 μg catechin equivalent/ mg dry extract (Cat. Eq. mg-1extract).
On the other hand, no differences were noticed for flavonoids contents. In fact, the amount
ranged from 15.63 to 16.67 μg Rutin Eq mg-1 extract for leaves, and from 10.61 to 17.56 μg
Rutin Eq mg-1 extract for stem bark.
UHPLC/MS investigation. The UHPLC/MS analysis was carried out in negative mode, phe-
nolic compounds were identified by examination of retention times, UV -visible and mass
spectra, corresponding to the different metabolites eluted from leaves and stem bark extracts
of F. angustifolia Vahl. the UHPLC chromatograms of the aqueous extract of chloroform
(FL5) and its native ethanolic extract (FL1) are presented in Fig 1, the molecular weights and
retention times collected from the analysis together with the identifications of the detected
metabolites are shown in Table 6.
Table 4. MTT assay. IC50 values (μg/mL), with 95% confidence range (in brackets) obtained by MTT assay after 72h treatment of Hep-G2 and MCF7 cell lines with leaves
and stem bark extracts of F.angustifolia Vahl.
Treatment Hep-G2 MCF-7
IC50 (confidence range) LOAEC IC50 (confidence range) LOAEC
FL1 713 (488–1041) 500 496 (281–871) 250
FL2 527 (326–853) 500 1047 (884–1240) 750
FL3 1644 (1453–1862) 1000 1053 (824–1344) 1000
FL4 680 (372–1241) 500 970 (732–1287) 500
FL5 441 (242–801) 125 479 (352–651) 250
FB1 530 (303–929) 500 682 (469–942) 500
FB2 626 (498–787) 500 886 (645–1218) 750
FB3 431 (286–649) 250 882 (627–1240) 750
FB4 777 (664–908) 500 634 (631–932) 100
FB5 504 (411–617) 250 437 (330–578) 125
LOAEC: Lowest Observable Adverse Effect Concentration (μg/mL), (Dunnett’s test, p< 0.05)
FL F.angustifolia Vahl. leaves; FB F.angustifolia Vahl. stem bark
1 Ethanolic; 2 Organic/Ethyl Acetat; 3 Aqueous/ Ethyl Acetat; 4 Organic/ Chloroform; 5 Aqueous/ Chloroform
https://doi.org/10.1371/journal.pone.0230690.t004
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The shared metabolites between these two extracts, with more intensities in the aqueous
phase (in bold, Table 6) are in the first place, oleuropein (4), a major compound, common to
Oleaceae family (especially Fraxinus species) derived from the biosynthetic pathway of a
secoiridoid [37], its main metabolites are tyrosol and hydroxytyrosol [38]. Two other metabo-
lites belonging to this same chemical group, ligtroside (6) with an intensity twice as high in the
Table 5. Extraction yield and quantitative phytochemicals screening. Extraction yield and quantitative phytochemicals screening of extracts from F. angustifolia Vahl.
F. angustifolia Vahl. Extraction Yield (g dry extract/100g of powder) Extraction content
Polyphenols (μg Cat. Eq. /mg dry extract) Flavonoids (μg Rut. Eq. /mg dry extract)
FL1 8.53 98.63 ± 6.25 16.22 ± 5.02
FL2 3.88 105.95 ± 1.45ns 16.67 ± 1.20ns
FL3 5.56 44.94 ± 4.38��� 15.90 ± 2.62ns
FL4 5.2 120.65 ± 2.83��� 16.67 ± 1.20ns
FL5 0.74 99.52 ± 1.65ns 15.63± 2.91ns
FB1 5.85 92.86 ± 2.91 11.68 ± 0.49
FB2 1.32 76.13 ± 0.94### 15.93 ± 5.09ns
FB3 4.25 75.30 ± 1.23### 10.61 ± 0.96ns
FB4 3.18 32.56 ± 0.94### 17.56 ± 3.55ns
FB5 0.48 207.08 ± 4.83### 14.25±3.02ns
Data are presented as means ± SD (n = 3). μg Cat. Eq.: microgramme catechin equivalent, μg Rut. Eq.: microgramme rutin equivalent.
ns Not significant
���p<0.001 compared to FL1
###p<0.001 compared to FSB1.�,# Significance (p<0.001) by One way ANOVA test, with Dunnett’s post test of GraphPad Prism Software. FL F.angustifolia Vahl. leaves;
FB F.angustifolia Vahl. stem bark; 1 Ethanolic; 2 Organic/Ethyl Acetat; 3 Aqueous/ Ethyl Acetat; 4 Organic/Chloroform; 5 Aqueous/ Chloroform
https://doi.org/10.1371/journal.pone.0230690.t005
Fig 1. Leaves HPLC chromatogram. HPLC chromatogram (254 nm) of the composition of the aqueous chloroform (FL5) extract and its native crude extract (FL1) of F.
angustifolia Vahl leaves. FL1: Ethanolic extract; FL5: aqueous/ chloroform extract.
https://doi.org/10.1371/journal.pone.0230690.g001
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aqueous extract as the ethanolic extract and the compound (5) supposed to be ligstrosidic acid,
according to the bibliographic data corresponding to the results of the UHPLC / MS analysis
of the fraction where this metabolite is the major one. It is also remarkable that these two
extracts share two flavonols glycosides, isoquercitrin (1) and rutin (3), they are glycoside deriv-
atives of quercetin, which were previously reported as the constituents of genus Fraxinus has
been reported [39]. There is also a compound whose intensity is not very different, elenolic
acid (7), which would come from the hydrolysis of oleuropein which releases hydroxytyrosol
and elenolic acid. Tyrosol, on the other hand, comes from the degradation of ligstroside [40].
Finally, we note the presence of a low intensity peak of a phenylethanoid, verbascoside (2), pre-
viously reported in several Fraxinus species.
HPLC chromatograms and identified metabolites in the aqueous extracts of chloroform
(FB5) and its native ethanolic extract (FB1) are Illustrated in Fig 2 and Table 7.
It is noted in this comparative figure that FB5 concentrated and selected mainly phenyletha-
noids and secoiridoids compared to the more diverse composition in metabolites with lower
incidences in the native extract (FB1). The two major compounds of this extract are calceolario-
side B and ligstroside. Their isomers and derivatives, namely at least two isomers of calceolario-
side B, the verbascoside and its isoverbascoside isomer, and its decaffeoyl derivative. Similarly,
lower levels were found for ligstroside, demethyl-ligstroside and ligstrosidic acid. This extract
also selected a small amount of a coumarin common in the genus Fraxinus, fraxin.
Discussion
Too often, treatments based on medicinal plants can cause serious health risks [41]. Thus, it
was consistent to assess the mutagenic and genotoxic activities of F. angustifolia Vahl. extracts
in order to exclude their eventual negative impact on genetic material.
Table 6. Retention times (tr) of the ions (m/z) and the molecular weights. Table of the retention times (tr) of the ions (m/z) and the molecular weights corresponding to
the peaks revealed in the HPLC/MS spectra of F. angustifolia Vahl. leaves extracts.
Extract N˚ tR (min) m/z Experimental Max MW Intensity Molecular formula Identified metabolite
FL1 1 1.0 181.10 182.11 20816 C9H10O4 Syringaldehyd
2 7.9 463.19 464.20 28659 C21H20O12 Isoquercitrin
3 10.5 609.20 610.21 52629 C27H30O16 Rutin
4 11.4 539.23 540.23 236032 C25H32O13 Oleuropein
5 12.5 569.24 570.25 266002 --- Ligstrosidic acid
6 13.1 523.24 524.24 98953 C25H32O12 Ligstroside
7 14.0 601.27 602.27 43358 --- Derivative of Elenolic acid
8 16.5 909.38 910.39 28220 --- Isomer of GL5
9 20.3 698.97 699.98 80336 --- Gallic acid dihexoside sinapoyl
10 20.4 532.97 533.98 117390 C24H22O14 Kaempferol-3-O-malonyl glucoside
11 21.0 255.26 256.27 27040 C15H12O4 Liquirtigenin
FL5 1 7.9 463.19 464.19 30623 C21H20O12 Isoquercitrin
2 9.2 623.25 624.26 12982 C29H36O15 Verbascoside /Isoverbascoside
3 10.5 609.20 610.21 16134 C27H30O16 Rutin
4 11.4 539.22 540.23 392912 C25H32O13 Oleuropein
5 12.5 569.24 570.24 276806 C26H34O14 Ligstrosidic acid
6 13.1 523.23 524.24 208500 C25H32O12 Ligstroside
7 14.0 601.26 602.27 69027 --- Derivative of Elenolic acid
FL: F. angustifolia Vahl. leaves; 1: Ethanolic extract; 5: Aqueous/chloroform extract
In Bold: identified metabolite with high intensity
https://doi.org/10.1371/journal.pone.0230690.t006
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In this initial report we demonstrated that the tested F. angustifolia Vahl. extracts did not
produce DNA lesions. The absence of genotoxicity/mutagenicity is not typical of all natural
products in use, since several medicinal plants, assayed with the umu and/or the Ames test, in
the presence or absence of the S9 metabolic activation, proved to be positive for genotoxicity/
mutagenicity [32, 42–44]. Polyphenols are a diverse class of compounds; many are favorable in
preventing disease and protecting the stability of the genome. However not all polyphenols
and not all their actions are necessarily advantageous. Some of them have mutagenic and/or
pro-oxidant effects. It was proven that several polyphenols, including quercetin, can bind to
DNA and this direct interaction may be an important mechanism of bacterial mutagenicity,
even those polyphenols that are negative in bacterial systems may be clastogenic in mamma-
lian cells [45].
Furthermore, conflicting results about the mutagenic potential of verbascoside, a pheny-
lethanoid compound, identified in F. angustifolia Vahl. when tested on TA 98 and TA 100, did
not induce frameshift and base-pair substitution mutations in the presence or absence of meta-
bolic system [46], but induced DNA damages on human lymphocytes, with an involvement of
PARP-1 and p53 expression through its caffeic acid moiety [47].
Recently, in vivo subsequent tests on Drosophila melanogaster and rabbit reported that ver-
bascoside do not give rise to any mutagenic activity at any of the tested concentrations [48–
50]. Besides poor in vivo bioavailability of verbascoside was reported and could be also related
to this behavior [51].
Substances with antigenotoxic and/or antimutagenic properties may be useful against the
damage caused by environmental mutagens. The antigenotoxic study of F. angustifolia Vahl.
Fig 2. Bark HPLC chromatogram. HPLC chromatogram (254 nm) of the composition of the aqueous chloroform (FSB5) extract and its native crude extract (FSB1) of F.
angustifolia Vahl stem bark. FB1 ethanolic extract; FB5 aqueous/ chloroform extract.
https://doi.org/10.1371/journal.pone.0230690.g002
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extracts was first evaluated by the umu test towards the direct mutagen 4-NQO, revealing to
have a strong antigenotoxic effect (FL5 and FB5 extracts, inhibition by 70%) besides a moder-
ate effect observed with the indirect mutagen 2-AA. This indicates that these extracts may not
be involved in 2-AA genotoxic action but in the 4-NQO mutagenic mechanism.
4-NQO induces intracellular oxidative stress; it can undergo redox cycling and generate
reactive oxygen species such as superoxide radical and hydrogen peroxide [52, 53]. Further-
more, F. angustifolia Vahl. has revealed a potent antioxidative capacity [19, 26]; Hence, the
possible mechanism of the observed antigenotoxic potency could involve the bioactive pheno-
lic antioxidant compounds present in the F. angustifolia Vahl. extracts which might interact
with the reactive intermediates of 4-NQO.
The second known mechanism of the carcinogenic action of 4-NQO is the formation of sta-
ble mono-adducts on purines [54, 55]. This damage could be repaired by the nucleotide exci-
sion repair pathway [54]. Moreover, the strain TA1553 /pSK 1002 is uvrb deficient [56]. Taken
altogether, these results indicate that, in addition to antioxidant activity F.angustifolia Vahl.,
leaves and stem bark extracts may exert their antimutagenic properties also by modulating the
DNA repair processes [57].
Umu test showed lower detection sensitivities to the weaker Ames positive chemicals of rel-
atively strong Ames positive [58]. Moreover, Oda in 2016 [59] concluded that umu and Ames
Table 7. Retention times (tr) of the ions (m/z) and the molecular weights. Table of the retention times (tr) of the ions (m/z) and the molecular weights corresponding to
the peaks revealed in the HPLC/MS spectra of F. angustifolia Vahl. stem bark extracts.
Extract N˚ tR (min) m/z Experimental Max MW Intensity Molecular formula Identified metabolite
FB 1 1 1.0 341.15 342.15 81408 C15H18O9 Caffeic acid glucoside
2 4.7 369.13 370.13 68630 C16H18O10 Fraxin
3 5.1 429.15 430.15 20964 --- ---
4 7.3 535.23 536.24 21362 C26H32O12 8-Hydroxypinoresinol-4/8-glucoside.
5 8.5 477.18 478.19 30486 C23H25O11 Calceolarioside A
6 9.2 623.25 624.26 95389 C29H36O15 Verbascoside
7 9.5 477.19 478.19 174206 C23H25O11 CalceolariosideB
8 10.3 623.25 624.26 67733 C29H36O15 Isoverbascoside
9 12.5 569.24 570.25 26693 C26H34O14 Ligstrosidic acid
10 13.1 523.23 524.24 28317 C25H32O12 Ligstroside
11 19.6 269.22 270.23 21594 C8H13O10 Apigenin
12 20.3 698.97 699.98 68940 --- Gallic acid dihexosidesinapoyl
13 20.5 532.98 533.98 120273 C24H22O14 Kaempferol-3-O-malonyl glucoside
14 21.0 255.26 256.27 62872 C15H12O4 Liquirtigenin
FB 5 1 4.7 369.12 370.13 10714 C16H18O10 Fraxin
2 6.5 477.18 478.19 27245 C23H25O11 Calceolarioside
3 7.9 477.18 478.19 12107 C23H25O11 Calceolarioside
4 9.2 623.25 624.26 81456 C29H36O15 Verbascoside
5 9.5 477.18 478.19 299210 C23H25O11 Calceolarioside B
6 9.9 509.21 510.22 27567 C24H30O12 demethyligstroside
7 10.3 623.25 624.26 50994 C29H36O15 Isoverbascoside
8 10.9 461.19 462.19 19841 C20H29O12 Decaffeoylverbascoside
9 12.5 569.24 570.24 51995 C26H34O14 Ligstrosidic acid
10 13.1 523.23 524.23 102076 C25H32O12 Ligstroside
FB: F. angustifolia Vahl. stem bark; 1: Ethanolic extract; 5: Aqueous/chloroform extract
In Bold: identified metabolite with high intensity
https://doi.org/10.1371/journal.pone.0230690.t007
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test are complementary and would be used together in order to broaden the detection capacity.
In fact, umu test detects damage to DNA by evaluating the expression level of the umu gene
product, which is one of the DNA repairing enzymes induced through the SOS response while
Ames assay detects the mutation of gene for histidine synthesis by growing a mutant colony
that is a phenotype of such mutation [58].
In the present study, a variation of Ames test was used to assess the antimutagenic activity
of F.angustifolia Vahl. extracts against other mutagens (2-NF, NaN3, 3-MC and CP) with dif-
ferent mutagenic mechanism than that used for umu test. In addition, extracts of F. angustifo-
lia Vahl. were subjected to two concentrations of the standard mutagens for better
understanding of the dose effect relation.
F. angustifolia Vahl. leaves and stem bark extracts exhibited a protective effect against low
concentrations of mutagens, on both strains TA98 and TA100 independently tested with or
without metabolic activation. Regarding high concentrations of standard mutagen, the extracts
were effective on TA100 and less active on TA98, when tested in the absence of metabolic acti-
vation. The extracts acted by interrupting several mutagenesis processes, indicating that they
may directly protect the DNA from damages, possibly by quick elimination of mutagens from
the bacteria before their interaction with the DNA. They may also facilitate or stimulate the
bacterial transmembrane export system to eliminate the mutagens, or interfere with the uptake
of mutagens into bacteria [57, 60]. However, the inhibition of mutagenesis is often complex,
involving multiple mechanisms [61].
Otherwise, cytotoxicity and selectivity of F. angustifolia Vahl. were examined on normal-
like cells (human fibroblasts, TelCOFS02MA), human hepatocarcinoma cells (HepG2) and
human adenocarcinoma cells (MCF-7). Overall, it is interesting to observe a correlation
between phytochemicals profile identified by HPLC/MS and the selectivity degree of the
extracts. FL1 and FL5 were selective towards the two cancer cell lines, and this may be due to
the high content of oleuropein and ligstrosidic acid detected in the two extracts; oleuropein is
a characteristic phenol largely distributed in Oleaceae family, and involved in a number of
exhaustively documented biological activities [62]. Oleuropein exhibited cytotoxic activity
against six tumoral cell lines, MCF-7, HepG2, Caco-2, A549, MDA, and DU145 [63]. Further-
more, Goldsmith and collaborators [64] assessed the anti-pancreatic cancer potential of oleur-
opein and its metabolite hydroxytyrosol on pancreatic cancer cells and non-tumorigenic
pancreas cells inducing apoptosis in tumor cells, and displaying a protective effect on non-
tumorigenic cells. The authors argued that this selectivity to the sensitivity of cancer cells is
due to ROS generation. In fact, many human cancer cell types exist in a highly oxidative state
compared to their normal tissues and, therefore, the selective activity of oleuropein on tumor
cells could be due to their increased sensitivity towards ROS [64].
Moreover, it has been previously shown that oleuropein inhibits cell proliferation on MCF7
and HepG2 by decreasing the gene expression involved in metastasis and invasion of tumoral
cells [65, 66]. Concerning ligstrosidic acid no data are available on biological activities and
therefore no conclusion can be drawn.
In stem bark extracts, only FB5 showed significant SI values with 2.52 for HepG2 and 2.90 for
MCF-7 while no selectivity was observed in the native crude extract FB1. Indeed, FB5 has the
highest amount of polyphenol among all extract, moreover a net difference in the intensity peak
of ligstroside and calceolarioside B in FB5 suggests that it could be involved in its antiproliferative
activity. There is no extensive data about studies testing the biological activity of ligstroside and
calceolarioside B. Principally, ligstroside aglycon was checked about possible implication against
two proteins involved in breast cancer, with significant results even at low doses [67, 68].
However, it cannot be excluded that some minor components identified in the different
extracts such as rutin, isoquercitrin, verbascoside and its isomer isoverbascoside may also
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exert pharmacological effects and therefore play a crucial role in the proprieties exerted in this
study [68, 69].
Conclusion
In conclusion, the results of the present study showed that F. angustifolia Vahl. leaves and
stem bark extracts alone had no mutagenic effect on the tested strains, either in the presence
or absence of metabolic activation. Moreover, significant antimutagenic activity of these
extracts against several mutagens, indicates that F. angustifolia Vahl. leaves and stem bark
extracts may directly protect DNA damage from mutagens, these in vitro test results would
raise the question of its relation to efficacy under in vivo conditions in which factors such as
bioavailability and metabolism must be taken into account.
More studies need to be carried out to assess the antimutagenic mechanisms of isolated
phytochemical components of leaves and stem bark extracts of F. angustifolia Vahl. In addition
to this, the antimutagenic activity of these extracts should be tested on in vivo model.
The strong cytotoxic activity and selectivity of FL1, FL5 and FB5 extracts against HepG2
and MCF-7 could be an indication on the potentiality of these extracts to be further screened
for antiproliferative or cytotoxic activities against a number of cancer cell lines. It could be fur-
ther studied for inhibitory effects on the invasion of cells at a non-lethal concentration.
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44. Abudayyak M, öZdemir Nath E, öZhan G. Toxic potentials of ten herbs commonly used for aphrodisiac
effect in Turkey. Turkish Journal of Medical Sciences. 2015; 45: 496–506. https://doi.org/10.3906/sag-
1401-153 PMID: 26281312
45. Ferguson LR. Role of plant polyphenols in genomic stability. Mutation Research/Fundamental and
Molecular Mechanisms of Mutagenesis. 2001; 475: 89–111. https://doi.org/10.1016/s0027-5107(01)
00073-2 PMID: 11295156
46. Henn JG, Steffens L, de Moura Sperotto ND, de Souza Ponce B, Verı́ssimo RM, Boaretto FBM, et al.
Toxicological evaluation of a standardized hydroethanolic extract from leaves of Plantago australis and
its major compound, verbascoside. Journal of Ethnopharmacology. 2019; 229: 145–156. https://doi.
org/10.1016/j.jep.2018.10.003 PMID: 30316886
47. Santoro A, Bianco G, Picerno P, Aquino RP, Autore G, Marzocco S, et al. Verminoside- and verbasco-
side-induced genotoxicity on human lymphocytes: Involvement of PARP-1 and p53 proteins. Toxicol-
ogy Letters. 2008; 178: 71–76. https://doi.org/10.1016/j.toxlet.2008.02.006 PMID: 18395372
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